Astrana Health Inc (ASTH)
Return on total capital
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | 108,808 | 104,264 | 106,010 | 103,294 | 27,016 |
| Long-term debt | US$ in thousands | 258,939 | 203,389 | 7,114 | 230,211 | 232,172 |
| Total stockholders’ equity | US$ in thousands | 614,218 | 542,561 | 448,167 | 330,824 | 191,549 |
| Return on total capital | 12.46% | 13.98% | 23.28% | 18.41% | 6.38% |
December 31, 2023 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $108,808K ÷ ($258,939K + $614,218K)
= 12.46%
Astrana Health Inc's return on total capital has shown fluctuations over the past five years. In 2023, the return on total capital was 12.46%, a decrease from the previous year's 13.98%. Despite this decrease, the return on total capital in 2023 remains relatively healthy compared to previous years.
The trend shows an improvement in return on total capital from 2019 to 2021, where it increased significantly from 6.38% in 2019 to 23.28% in 2021, indicating a strong performance and efficient use of capital during those years. However, there was a slight decline in 2022 and a further decrease in 2023.
Overall, Astrana Health Inc has demonstrated the ability to generate returns on its total capital investment, although there have been fluctuations in performance over the past five years. Monitoring and analyzing this ratio over time can provide valuable insights into the company's financial health and efficiency in utilizing its capital resources.